Patents by Inventor Bruce Ganem

Bruce Ganem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enone cancer therapeutics
    Patent number: 7569711
    Abstract: Described herein are new enone derivatives and conjugates. Additionally, methods for synthesizing these new enones are also disclosed. These compounds can be employed in cancer therapy.
    Type: Grant
    Filed: December 7, 2004
    Date of Patent: August 4, 2009
    Assignee: Cornell Univeristy
    Inventors: Bruce Ganem, Donald J. Creighton, Diana S. Hamilton, Zhebo Ding
  • Sterilization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
    Publication number: 20090110596
    Abstract: Sterilization methods and apparatus are effective to achieve a 6-log reduction in CFUs of industry standard bacteria and bacterial spores, i.e., B. stearothermophilus and B. subtilis spores, by subjecting sterilizable materials to a chemical additive-containing carbon dioxide sterilant fluid at or near its supercritical pressure and temperature conditions. Most preferably, the chemical additive-containing supercritical carbon dioxide sterilant fluid is agitated during sterilization, e.g., via mechanical agitation or via pressure cycling.
    Type: Application
    Filed: December 29, 2008
    Publication date: April 30, 2009
    Inventors: Timothy Wayne Christensen, David Carroll Burns, Angela Lydia White, Bruce Ganem, Anthony Romey Eisenhut
  • Sterilization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
    Publication number: 20070003432
    Abstract: Sterilization methods and apparatus are effective to achieve a 6-log reduction in CFUs of industry standard bacteria and bacterial spores, i.e., B. stearothermophilus and B. subtilis spores, by subjecting sterilizable materials to a chemical additive-containing carbon dioxide sterilant fluid at or near its supercritical pressure and temperature conditions. Most preferably, the chemical additive-containing supercritical carbon dioxide sterilant fluid is agitated during sterilization, e.g., via mechanical agitation or via pressure cycling.
    Type: Application
    Filed: September 6, 2006
    Publication date: January 4, 2007
    Inventors: Timothy Christensen, David Burns, Angela White, Bruce Ganem, Anthony Eisenhut
  • Sterialization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
    Patent number: 7108832
    Abstract: Sterilization methods and apparatus are effective to achieve a 6-log reduction in CFUs of industry standard bacteria and bacterial spores, i.e., B. stearothermophilus and B. subtilis spores, by subjecting sterilizable materials to a chemical additive-containing carbon dioxide sterilant fluid at or near its supercritical pressure and temperature conditions. Most preferably, the chemical additive-containing supercritical carbon dioxide sterilant fluid is agitated during sterilization, e.g., via mechanical agitation or via pressure cycling.
    Type: Grant
    Filed: June 17, 2004
    Date of Patent: September 19, 2006
    Assignee: NovaSterilis Inc.
    Inventors: Timothy Wayne Christensen, David Carroll Burns, Angela Lydia White, Bruce Ganem, Anthony Romey Eisenhut
  • Enone cancer therapeutics
    Publication number: 20050233975
    Abstract: Described herein are new enone derivatives and conjugates. Additionally, methods for synthesizing these new enones are also disclosed. These compounds can be employed in cancer therapy.
    Type: Application
    Filed: December 7, 2004
    Publication date: October 20, 2005
    Applicant: Cornell Research Foundation, Inc.
    Inventors: Bruce Ganem, Donald Creighton, Diana Hamilton, Zhebo Ding
  • Sterilization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
    Publication number: 20050025667
    Abstract: Sterilization methods and apparatus are effective to achieve a 6-log reduction in CFUs of industry standard bacteria and bacterial spores, i.e., B. stearothermophilus and B. subtilis spores, by subjecting sterilizable materials to a chemical additive-containing carbon dioxide sterilant fluid at or near its supercritical pressure and temperature conditions. Most preferably, the chemical additive-containing supercritical carbon dioxide sterilant fluid is agitated during sterilization, e.g., via mechanical agitation or via pressure cycling.
    Type: Application
    Filed: June 17, 2004
    Publication date: February 3, 2005
    Applicant: NovaSterilis Inc.
    Inventors: Timothy Christensen, David Burns, Angela White, Bruce Ganem, Anthony Eisenhut
  • Enone cancer therapeutics
    Publication number: 20030191066
    Abstract: New enone derivatives and conjugates are described. These compounds can be used as cancer therapeutics.
    Type: Application
    Filed: March 15, 2002
    Publication date: October 9, 2003
    Applicant: Cornell Research Foundation, Inc.
    Inventors: Bruce Ganem, Donald J. Creighton, Diana S. Hamilton, Zhebo Ding
  • Monosaccharide analog-based glycosidase inhbitors
    Patent number: 5663355
    Abstract: Broad spectrum glycosidase inhibitors are produced from monosaccharide lactams by conversion to amidines, amidrazones or amidoximes. The inhibitors have the general formula: ##STR1## wherein the N and C are joined as part of a monosaccharide azaanalog ring and wherein --NRQ, together with the nitrogen and carbon atoms, form a chemical group selected from amidines, amidrazones, and amidoximes.
    Type: Grant
    Filed: January 19, 1995
    Date of Patent: September 2, 1997
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Bruce Ganem, Michael K. Tong, George Papandreou
  • Non-cyclic esters for pest control
    Patent number: 5661181
    Abstract: A method for repelling insects from plants with non-cyclic esters is disclosed. The esters are prepared from a non-cyclic polyhydroxyl compound having from about 3 to about 5 carbon atoms and at least three hydroxyl groups and a carboxylic acid. In the esters at least two of the hydroxyl groups are esterified and the total number of carbon atoms in all of the ester groups is from about 9 to about 19.
    Type: Grant
    Filed: February 16, 1995
    Date of Patent: August 26, 1997
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Martha A. Mutschler, Bruce Ganem
  • Monosaccharide analog-based glycosidase inhibitors
    Patent number: 5434266
    Abstract: Broad spectrum glycosidase inhibitors are produced from monosaccharide lactams by conversion to amidines, amidrazones, or amidoximes. The inhibitors have the general formula: ##STR1## wherein the N and C are joined as part of a monosaccharide azaanalog ring and wherein --NRQ, together with the nitrogen and carbon atoms, form a chemical group selected from amidines, amidrazones, and amidoximes.
    Type: Grant
    Filed: April 29, 1993
    Date of Patent: July 18, 1995
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Bruce Ganem, Michael K. Tong, George Papandreou
  • Monosaccharide analog-based glycosidase inhibitors
    Patent number: 5231185
    Abstract: Broad spectrum glycosidase inhibitors are produced from monosaccharide lactams by conversion to amidines, amidrazones, or amidoximes. The inhibitors have the general formula: ##STR1## wherein the N and C are joined as part of a monosaccharide azaanalog ring and wherein --NRQ, together with the nitrogen and carbon atoms, form a chemical group selected from amidines, amidrazones, and amidoximes.
    Type: Grant
    Filed: July 23, 1991
    Date of Patent: July 27, 1993
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Bruce Ganem, Michael K. Tong, George Papandreou